Immunoglobulin therapy in immunohematological disorders

Indian Journal of Pediatrics

Volumn 65, Issue 5, 1998, Pages 681-690

  Choudhry, V P ^a   Mahapatra, M ^a   Kashyap, R ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Autoimmune hemolytic anemia; Immune neutropenia; Immune thrombocytopenic purpura; Immunoglobulins

Indexed keywords

BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 9; IMMUNOGLOBULIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN D; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ANTIGEN BINDING; AUTOIMMUNE DISEASE; AUTOIMMUNE HEMOLYTIC ANEMIA; BONE MARROW TRANSPLANTATION; CONFERENCE PAPER; DRUG CLEARANCE; DRUG CONTRAINDICATION; DRUG DISTRIBUTION; DRUG HALF LIFE; FEVER; HEMATOLOGIC DISEASE; HEMOLYSIS; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOGLOBULIN STRUCTURE; IMMUNOREGULATION; IMMUNOTHERAPY; INTRAVENOUS DRUG ADMINISTRATION; NEUTROPENIA; RHESUS ISOIMMUNIZATION; THORAX PAIN; THROMBOCYTOPENIA;

EID: 0031712169     PISSN: 00195456     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02731042     Document Type: Conference Paper

References (54)

1. Stokes J Jr, Maris EP, Gellis SS. Chemical, clinical and immunological studies on the products of human plasma fractionation XI. The use of concentrated normal human serum gammaglobulin (human immune serum globulin) in the prophylaxis and treatment of measles. J Clin invest 1944; 23 : 531-540.
2. Eibl MM, Wedgwood RJ. Intravenous immunoglobulin : a review. Immundefic Rev 1989; 1 (suppl) : 1-42.
3. Buckley RH, Schiff RI. The use of intravenous immune globulin in immunodeficiency disease. N Engi J Med 1991; 325 : 110-117.
4. Kaveri SV, Dietrich G and Kazatchkine MD. Can intravenous immunoglobulin treatment regulate autoimmune responses. Sem Hematol 1992; 29 (Suppl 2) : 64-71.
5. Jerne NK. The immune system : a web of V-domains, New York, Academic Press, 1976.
6. Huizinga TW, van der Schoot CE, Jost C, et al. The PI-linked receptor FcRIII is relased on stimulation of neutrophils. Nature 1988; 333 : 667-669.
7. Unkeless JC. Function and heterogeneity of human Fc receptors for immunoglobulin G. J Clin Invest 1989; 83 : 355-361.
8. Dwyer JM, Johnson C. The use of concanavalin A to study the immunoregulation of human T cells. Clin Exp Immunol 1981; 46 : 237-249.
9. Dorf ME, Collins M, Whitters MJ et al. Antigen specific suppressor cells, receptors, and factors. In : Meclchers F, Albert ED, von Boehmer H, et al (eds) Progress in Immunology VII Berlin, Germany : Springer-Verlag, 1989; 874-881.
10. Kearney JF. Idiotypic networks. In : Paul WE (ed). Fundamental Immunology 2 ed. New York : Raven Press, 1989; 663-676.
11. Abdou NI, Wall H, Lindsley HB, Hasley JF, Susuki T. Network theory in autoimmunity : in vitro suppression of serum anti-DNA antibody binding to DNA by anti-idiotypic antibody in systemic lupus erythematosus. J Clin Invest 1981; 67 : 1297-1304.
12. Anderson CL. Human IgG Fc receptors. Clin Immunol Immunopathol 1989; 53 : 63-71.
13. Intravenous immune globulin : prevention and treatment of disease. NIH consensus Development Conference. Consensus statement. May 21-23, 1990; vol 8. No. 5. Bethesda, Md : Department of Health and Human Services 1990.
14. Intravenous globulin therapy, clinical benefits and future prospects, summary of discussions held during an International Roundtable Barcelona. June 1994, Ed. Kazatckine MD. The Parthenor Publishing Group Inc. 1995.
15. Imbach P (Ed). Immunotherapy with intravenous immunoglobulins. London Academic Press 1991.
16. Dwyer JM. Manipulating the immune system with immune globulin. New Eng J Med 1992; 326 : 107-116.
17. Kaveri SV, Dietrich G and Kazatchkine MD. Can intravenous immunoglobulin treatment regulate autoimmune response. Sem Hematol 1992; 29 (suppl 2) : 64-71.
18. Imbach P, Barandin S, d' Apuzzo V et al. High dose intravenous gamma-globulin for idiopathic thrombocytopenic purpura in childhood. Lancet 1981; 1 : 1228-1231.
19. Imbach P, Wagner HP, Berchtold W, et al. Intravenous immunoglobulin versus oral corticosteroids in acute immune thrombocytopenic purpura in childhood. Lancet 1985; 2 : 464-468.
20. Imholz B, Imback P, Baumgartner C. Intravenous immunoglobulin (iv IgG) for previously treated acute or for chronic idioptathic thrombocytopenic purpura (ITP) in childhood : a prospective multicentric study. Blut 1988; 56 : 63-48.
21. Bussel JP, and Phann LC. Intravenous treatment with gamma-globulin in adults with immune thrombocytopenic purpura : review of the literature. Vox Sang 1987; 52 : 206-211.
22. Newland AC. Clinical and therapeutic aspects and treatment with IV-IgG. In : Imbach P (ed) Idiopathic thrombocytopenia. Proceedings of a workshop (Bern : Pharmanual, Pharmalibri) 1986; 63-72.
23. Choudhry VP. Idiopathic thrombocytopenic purpura. Pathogenesis and Management in Recent Advances in Pediatrics. Gupta S (Ed) Jaypee publisers, 1998; vol. 8, : 66-81.
24. Choudhry VP, Kashyap R and Pati HP. Controversies in the management of idiopathic thrombocytopenic purpura. Ind J Pediatr 1998; 65 : 401-407.
25. Samuels P, Bussel JB, Braitman LE et al. Estimation of the risk of thrombocytopenia in the offspring of pregnant women with presumed immune thrombocytopenic purpura. N Engl J Med 1990 : 323 : 229-235.
26. Burrows RF and Kelton JG. Perinatal thrombocytopenia. Clin Perinatology 1995; 22 : 779-801.
27. Blachette VS, Chen L, Salomon de Friedberg Z, Hogan VA, Trudel E, Decary F. Alloimmune to the PLA Platelet antigen : results of a prospective study. Br J Haematol 1990; 74 : 704-215.
28. Mueller-Eckhardt C, Kiefel V, Grubert A. et al. 348 cases of suspected neonatal alloimmune thrombocytopenia. Lancet 1989; 1 : 363-366.
29. Bussel JB. Neonatal alloimmune thrombocytopenia : prospective case accumulation study (abstract). Pediatr Res 1988; 23 : 337A.
30. Reznikoff-Etivant MF. Management of alloimmune neonatal and antenatal thrombocytopenia. Vox Sang 1988; 55 : 195-201.
31. Clark AL and Gall SA. Clinical uses of intravenous immunoglobulin in pregnancy. Am J Obstet Gynecol 1997.; 176 : 241-253.
32. Bussel JB, Berkowitz RL, McFarland JG, Lynch L, Chitkara U. Antenatal-treatment of neonatal alloimmune thrombocytopenia. N Engl J Med 1988; 319 : 1374-1378.
33. Lynch L, Bussel JB, McFarland JG, Chitkara U, Berkowitz RL. Antenatal treatment of alloimmune thrombocytopenia. Obstet Gynecol 1992; 80 : 67-71.
34. Imbach PA. Management of immune thrombocytopenic purpura and other immunological cytopenias with human intravenous immunoglobulins. In : Rewald E and Morell A (ed). Immunomodulation by intravenous immunoglobulins. Parthenon Publishing Group 1993; 131-141.
35. Bussel J, Lalezari P and Fikrig. Intravenous treatment with gamma-globulin of autoimmune neutropenia of infancy. J Pediatr 1988; 112 : 298-301.
36. Besa EC. Rapid transient reversal of anemia and long term effects of maintenance intravenous immunoglobulin for autoimmune hemolytic anemia in patients with lymphoproliferative disorders. Am J Med 1988; 84 : 691-698.
37. Muller-Eakhardt C, Salama A, Mahn I, et al. Lack of efficacy of high dose intravenous immunoglobulin in autoimmune hemolytic anemia. A clue to its mechanism. Scand J Haematol 1985; 34 : 394-400.
38. Berlin G, Selbing A, Ryden G. Rhesus haemolytic disease treated with high dose intravenous immunoglobulin. Lancet 1985; 1 : 1153.
39. De La Camara C, Arrieta R, Gonzalez A, Igelesias E, Omenara F. High-dose intravenous immunoglobulin as the sole prenatal treatment for severe Rh immunization. N Engl J Med 1988; 318 : 519-520.
40. Margulies M, Voto LS, Mathet E, Margulies M. High-dose intravenous IgG for the treatment of severe rhesus allommunization. Vox Sang 1991; 61 : 181-189.
41. Scifried E, Gaedicke G, Pindus G, Rasche H The treatment of hemophilia. An inhibitor with high dose intravenous immunoglobulin. Bult 1984; 48 : 397-401.
42. Sultan Y, Kazatchline MD, Maisonneuve P, Nydegger UE. Anti-idiotypic suppression of autoantibodies to factor VIII (antihaemophilic factor) by high-dose intravenous gammaglobulin. Lancet 1984; 2 : 765-768.
43. Lafferty TE, Smith JB, Schuster SJ and De horatius RJ. Treatment of acquried factor VIII inhibitor using intravenous immunoglobulin in two patients with systemic lupus erythematosus. Arthitis Rheum 1997; 40 : 775-778.
44. Nilsson IM, Berntorp E, Zettervall O. Induction of immune tolerance in patients with hemophilia and antibodies to factor VIII. N Engl J Med 1988; 318 : 947-950.
45. Tutschka P. Bone marrow transplantation in intravenous immunoglobulin. Clinical benefits and future prospects. Summary of discussion held during an international round table Barcelona. June 1994 Kazatchkine MD ed, Parthenon Publishing Group 1995; 77-80.
46. Berkman SA, Lee MI and Gale RP Clinical uses of intravenous immunoglobulins. A review. Ann Intern Med 1990; 112 : 278-292.
47. Copelan EA, Strohm PL, Kennedy MS, Tutchka PJ. Hemolysis following intravenous immune globulin therapy. Transfusion 1986; 26 : 410-412.
48. Woodruff RK, Grigg AP, Firkin FC, Smith IL. Fatal thrombotic events during treatment of autoimmune thrombocytopenia with intravenous immunoglobulin in elderly patients (letter). Lancet 1986; 2 : 217-218.
49. Centers for Disease Control. Safety of therapeutic immune globulin preparations. with respect to transmission of human T lymphotropic virus type III/lymphadenopathy-associated virus infection. MMWR Morb Mortal Wkly Rep 1986; 35 : 231-233.
50. Zuck TF, Preston MS, Tankersley DL, et al. More on partitioning and inactivation of AIDS virus in immunoglobulin preparations (letter). N Engl J Med 1986; 314 : 1454-1455.
51. White WB, Ryan RW, Staley DD, Ballow M. Passive transfer of antibodies to human T-cell lymphotropic virus type III in patients receiving high-dose intravenous immunoglobulin. JAMA 1986; 255 : 2602-2603.
52. Schiff RI. Transmission of viral infections through intravenous immune globulin. N Engl J Med 1994; 331 : 1649-1650.
53. Centers of Disease Control and Prevention. Outbreak of hepatitis C associated with intravenous immunoglobulin administration-United States, October, 1993-June 1994 MMWR Morb Mortal Wkly Rep 1994; 43 : 505-509.
54. Thomas A Ratko, Burnett DA, Foulke GE, Matuszewski KA, Sacher RA. Recommendations for off-label use of intravenously administered immunoglobulin preparations. JAMA 1995; 273 : 1865-1870.